Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials (Q38481358)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 February 2007

Language	Label	Description	Also known as
English	Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials	scientific article published on 16 February 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

B Makoschey

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

D Sonnemans

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

J Muñoz Bielsa

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

P Franken

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

M Mars

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

L Santos

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

M Alvarez

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

16 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

6140-6145

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

BVD control in Europe: current status and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

Principles for eradication of bovine viral diarrhoea virus (BVDV) infections in cattle populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

Antibody responses of naive cattle to two inactivated bovine viral diarrhoea virus vaccines, measured by indirect and blocking ELISAS and virus neutralisation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

The application of monoclonal antibody panels to characterize pestivirus isolates from ruminants in Great Britain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

Persistence of bovine herpesvirus-1-specific antibodies in cattle after intranasal vaccination with a live virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

Experiences from the Danish programme for eradication of bovine virus diarrhoea (BVD) 1994-1998 with special reference to legislation and causes of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

Diagnostic assays applied in BVDV control in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

An ELISA detecting antibody to conserved pestivirus epitopes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.110

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.01.110

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38481358&oldid=1775141421"